United States Drug Enforcement Administration

WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

WASHINGTON – Federal and local law enforcement announced the arrests of 11 more alleged members of a fentanyl drug distribution network responsible for bringing hundreds of thousands of fake Oxycodone (M30) pills from California to D.C. Today's announcement was made by DEA Administrator Anne Milgram, U.S. Attorney Matthew M. Graves...

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...

WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...

Washington, D.C. - Yesterday, a federal jury in Maryland convicted two El Salvadorian nationals for conspiring to participate in La Mara Salvatrucha, a transnational criminal enterprise, commonly known as MS-13. Junior Noe Alvarado-Requeno, aka Insolente, aka Trankilo, 25, and Miguel Angel Corea Diaz, aka Reaper, 39, were convicted of multiple...

Washington, D.C. - A Mexican national was extradited from Brazil to the United States on Nov. 10 to face international drug trafficking charges. Jose Gonzalez-Valencia, aka Jafett Arias-Becerra, aka La Chepa, aka Camaron, and aka Santy, 46, arrived in the United States on Wednesday and made his initial court appearance...

WASHINGTON, D.C. - Damian Williams, the United States Attorney for the Southern District of New York, John J. Durham, Director of Joint Task Force Vulcan (“JTFV”), Anne Milgram, Administrator of the Drug Enforcement Administration (“DEA”), Jay Greenberg, Acting Assistant Director of the Criminal Investigative Division of the Federal Bureau of...